ASRS
CBAY

Arizona State Retirement System’s Cymabay Therapeutics CBAY Stock Holding History

Arizona State Retirement System’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,048
Closed -$521K – 2172
2023
Q4 		$521K Sell
22,048
-164
-0.7% -$2.92K ﹤0.01% 1422
2023
Q3 		$331K Buy
22,212
+1,716
+8% +$22.8K ﹤0.01% 1611
2023
Q2 		$224K Sell
20,496
-4,040
-16% -$37.6K ﹤0.01% 1892
2023
Q1 		$214K Buy
+24,536
New +$196K ﹤0.01% 1899
2021
Q2 		– Sell
-14,037
Closed -$64K – 2255
2021
Q1 		$64K Buy
14,037
+52
+0.4% +$280 ﹤0.01% 2131
2020
Q4 		$80K Buy
+13,985
New +$106K ﹤0.01% 2082
2020
Q2 		– Sell
-14,516
Closed -$21K – 1904
2020
Q1 		$21K Buy
+14,516
New +$24.4K ﹤0.01% 1807

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Arizona State Retirement System's CBAY Position: Q1 2024 in Review

Arizona State Retirement System sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 22,048 shares — an estimated $521K sold.

Arizona State Retirement System first reported a position in CBAY in Q1 2020 and held it in 7 quarters. The position peaked at $521K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Arizona State Retirement System reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Arizona State Retirement System sold 22,048 Cymabay Therapeutics shares in Q1 2024, an estimated $521K.
  • Arizona State Retirement System first reported a position in Cymabay Therapeutics in Q1 2020 and held it in 7 quarters.
  • Arizona State Retirement System's Cymabay Therapeutics position peaked at $521K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Arizona State Retirement System's 13F filing for Q1 2024, filed 7 May 2024.